Advances in the development of an early detection kit for bowel cancer

September 25, 2012
DNA microarray slide before use. Photograph: UPM.

Rubén Armañanzas and Pedro Larrañaga, researchers of the Computational Intelligence Group at the Universidad Politécnica de Madrid's Facultad de Informática have used advanced statistical and data mining techniques to filter information about the activity of over 22,000 genes and have managed to separate tumoural from non-tumoural samples with a precision of 94.45%.

This is the UPM's contribution to a joint effort among several Spanish institutions to assemble a genetic test for early detection. The goal of the study is to develop a low-cost device integrating biomarker measurement and mathematical models.

At present, detection is primarily based on the result of biopsies of polyps identified during a colonoscopy. However, this is a highly invasive technique that often comes too late.

The study started with the analysis of the genetic activity of over 22,000 genes simultaneously using . All this information was filtered using advanced statistical and high-dimensional .

This led to the identification of a small subset of genes that behaved differently in tumoural and non-tumoural samples. A classifier or diagnostic predictor can be built by combining the expression patterns using complex mathematical models.

94.45% precision

Based on the gene panel, known in the technical jargon as biomarkers, the mathematical models are able to classify a new set of tumoural or non-tumoural samples with a precision of 94.45%.

As mentioned earlier, the final goal of the study is to be able to develop a low-cost device integrating the measurement of the biomarker panel and mathematical models. Its use in clinical practice could be helpful for early bowel , while at the same time reducing costs and inconvenience to patients.

The project kicked off in 2005 and has been developed in several phases. It has involved patient recruitment and informed consent, DNA microarray-based laboratory testing, computational analysis using machine learning techniques and validation.

The results have been published in BMC Cancer. Despite the promising results, population studies are now required to further validate the findings. These studies are now under way and are expected to return new results in the coming years.

Explore further: Gene expression changes in nasal cells may help identify lung cancer in earliest stages

More information: Garcia-Bilbao, A; Armananzas, R; Ispizua, Z; Calvo, B; Alonso-Varona, A; Inza, I; Larranaga, P; Lopez-Vivanco, G; Suarez-Merino, B; Betanzos, M. Identification of a biomarker panel for colorectal cancer diagnosis, BMC CANCER, 12 10.1186/1471-2407-12-43 JAN 26 2012

Related Stories

Gene expression changes in nasal cells may help identify lung cancer in earliest stages

May 15, 2011
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest – and most treatable – stages, according to a study conducted by researchers ...

Potential for earlier diagnosis of ovarian cancer

January 25, 2012
(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.